Selected research
Market Analysis & Forecast
Global Pet Gut Microbiome Testing Market Analysis and Forecast 2026-2032
Market perspective
The global Pet Gut Microbiome Testing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Pet Gut Microbiome Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Pet Gut Microbiome Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Pet Gut Microbiome Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Pet Gut Microbiome Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Pet Gut Microbiome Testing include The Natural Vet, Embark Vet, MiDOG, Treat Therapeutics, AnimalBiome, Nom Nom and PetBiome, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Pet Gut Microbiome Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Pet Gut Microbiome Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for Pet Gut Microbiome Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pet Gut Microbiome Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pet Gut Microbiome Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pet Gut Microbiome Testing revenue, projected growth trends, production technology, application and end-user industry.
Pet Gut Microbiome Testing Segment by Company
The Natural Vet
Embark Vet
MiDOG
Treat Therapeutics
AnimalBiome
Nom Nom
PetBiome
Pet Gut Microbiome Testing Segment by Type
DNA Test
Culturing Test
Pet Gut Microbiome Testing Segment by Application
Cat
Dog
Pet Gut Microbiome Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Gut Microbiome Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pet Gut Microbiome Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Gut Microbiome Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Pet Gut Microbiome Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Pet Gut Microbiome Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pet Gut Microbiome Testing revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- DNA Test
- Culturing Test
Applications
- Cat
- Dog
Companies covered
- The Natural Vet
- Embark Vet
- MiDOG
- Treat Therapeutics
- AnimalBiome
- Nom Nom
- PetBiome
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Pet Gut Microbiome Testing Market by Type
- 1.2.1 Global Pet Gut Microbiome Testing Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 DNA Test
- 1.2.3 Culturing Test
- 1.3 Pet Gut Microbiome Testing Market by Application
- 1.3.1 Global Pet Gut Microbiome Testing Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Cat
- 1.3.3 Dog
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Pet Gut Microbiome Testing Market Dynamics
- 2.1 Pet Gut Microbiome Testing Industry Trends
- 2.2 Pet Gut Microbiome Testing Industry Drivers
- 2.3 Pet Gut Microbiome Testing Industry Opportunities and Challenges
- 2.4 Pet Gut Microbiome Testing Industry Restraints
3 Global Growth Perspective
- 3.1 Global Pet Gut Microbiome Testing Market Perspective (2021-2032)
- 3.2 Global Pet Gut Microbiome Testing Growth Trends by Region
- 3.2.1 Global Pet Gut Microbiome Testing Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Pet Gut Microbiome Testing Market Size by Region (2021-2026)
- 3.2.3 Global Pet Gut Microbiome Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Pet Gut Microbiome Testing Revenue by Players
- 4.1.1 Global Pet Gut Microbiome Testing Revenue by Players (2021-2026)
- 4.1.2 Global Pet Gut Microbiome Testing Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Pet Gut Microbiome Testing Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Pet Gut Microbiome Testing Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Pet Gut Microbiome Testing Key Players Headquarters & Area Served
- 4.4 Global Pet Gut Microbiome Testing Players, Product Type & Application
- 4.5 Global Pet Gut Microbiome Testing Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Pet Gut Microbiome Testing Market CR5 and HHI
- 4.6.3 2025 Pet Gut Microbiome Testing Tier 1, Tier 2, and Tier 3
5 Pet Gut Microbiome Testing Market Size by Type
- 5.1 Global Pet Gut Microbiome Testing Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Pet Gut Microbiome Testing Revenue by Type (2021-2032)
- 5.3 Global Pet Gut Microbiome Testing Revenue Market Share by Type (2021-2032)
6 Pet Gut Microbiome Testing Market Size by Application
- 6.1 Global Pet Gut Microbiome Testing Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Pet Gut Microbiome Testing Revenue by Application (2021-2032)
- 6.3 Global Pet Gut Microbiome Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 The Natural Vet
- 7.1.1 The Natural Vet Company Information
- 7.1.2 The Natural Vet Business Overview
- 7.1.3 The Natural Vet Pet Gut Microbiome Testing Revenue and Gross Margin (2021-2026)
- 7.1.4 The Natural Vet Pet Gut Microbiome Testing Product Portfolio
- 7.1.5 The Natural Vet Recent Developments
- 7.2 Embark Vet
- 7.2.1 Embark Vet Company Information
- 7.2.2 Embark Vet Business Overview
- 7.2.3 Embark Vet Pet Gut Microbiome Testing Revenue and Gross Margin (2021-2026)
- 7.2.4 Embark Vet Pet Gut Microbiome Testing Product Portfolio
- 7.2.5 Embark Vet Recent Developments
- 7.3 MiDOG
- 7.3.1 MiDOG Company Information
- 7.3.2 MiDOG Business Overview
- 7.3.3 MiDOG Pet Gut Microbiome Testing Revenue and Gross Margin (2021-2026)
- 7.3.4 MiDOG Pet Gut Microbiome Testing Product Portfolio
- 7.3.5 MiDOG Recent Developments
- 7.4 Treat Therapeutics
- 7.4.1 Treat Therapeutics Company Information
- 7.4.2 Treat Therapeutics Business Overview
- 7.4.3 Treat Therapeutics Pet Gut Microbiome Testing Revenue and Gross Margin (2021-2026)
- 7.4.4 Treat Therapeutics Pet Gut Microbiome Testing Product Portfolio
- 7.4.5 Treat Therapeutics Recent Developments
- 7.5 AnimalBiome
- 7.5.1 AnimalBiome Company Information
- 7.5.2 AnimalBiome Business Overview
- 7.5.3 AnimalBiome Pet Gut Microbiome Testing Revenue and Gross Margin (2021-2026)
- 7.5.4 AnimalBiome Pet Gut Microbiome Testing Product Portfolio
- 7.5.5 AnimalBiome Recent Developments
- 7.6 Nom Nom
- 7.6.1 Nom Nom Company Information
- 7.6.2 Nom Nom Business Overview
- 7.6.3 Nom Nom Pet Gut Microbiome Testing Revenue and Gross Margin (2021-2026)
- 7.6.4 Nom Nom Pet Gut Microbiome Testing Product Portfolio
- 7.6.5 Nom Nom Recent Developments
- 7.7 PetBiome
- 7.7.1 PetBiome Company Information
- 7.7.2 PetBiome Business Overview
- 7.7.3 PetBiome Pet Gut Microbiome Testing Revenue and Gross Margin (2021-2026)
- 7.7.4 PetBiome Pet Gut Microbiome Testing Product Portfolio
- 7.7.5 PetBiome Recent Developments
8 North America
- 8.1 North America Pet Gut Microbiome Testing Revenue (2021-2032)
- 8.2 North America Pet Gut Microbiome Testing Revenue by Type (2021-2032)
- 8.2.1 North America Pet Gut Microbiome Testing Revenue by Type (2021-2026)
- 8.2.2 North America Pet Gut Microbiome Testing Revenue by Type (2027-2032)
- 8.3 North America Pet Gut Microbiome Testing Revenue Share by Type (2021-2032)
- 8.4 North America Pet Gut Microbiome Testing Revenue by Application (2021-2032)
- 8.4.1 North America Pet Gut Microbiome Testing Revenue by Application (2021-2026)
- 8.4.2 North America Pet Gut Microbiome Testing Revenue by Application (2027-2032)
- 8.5 North America Pet Gut Microbiome Testing Revenue Share by Application (2021-2032)
- 8.6 North America Pet Gut Microbiome Testing Revenue by Country
- 8.6.1 North America Pet Gut Microbiome Testing Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Pet Gut Microbiome Testing Revenue by Country (2021-2026)
- 8.6.3 North America Pet Gut Microbiome Testing Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Pet Gut Microbiome Testing Revenue (2021-2032)
- 9.2 Europe Pet Gut Microbiome Testing Revenue by Type (2021-2032)
- 9.2.1 Europe Pet Gut Microbiome Testing Revenue by Type (2021-2026)
- 9.2.2 Europe Pet Gut Microbiome Testing Revenue by Type (2027-2032)
- 9.3 Europe Pet Gut Microbiome Testing Revenue Share by Type (2021-2032)
- 9.4 Europe Pet Gut Microbiome Testing Revenue by Application (2021-2032)
- 9.4.1 Europe Pet Gut Microbiome Testing Revenue by Application (2021-2026)
- 9.4.2 Europe Pet Gut Microbiome Testing Revenue by Application (2027-2032)
- 9.5 Europe Pet Gut Microbiome Testing Revenue Share by Application (2021-2032)
- 9.6 Europe Pet Gut Microbiome Testing Revenue by Country
- 9.6.1 Europe Pet Gut Microbiome Testing Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Pet Gut Microbiome Testing Revenue by Country (2021-2026)
- 9.6.3 Europe Pet Gut Microbiome Testing Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Pet Gut Microbiome Testing Revenue (2021-2032)
- 10.2 China Pet Gut Microbiome Testing Revenue by Type (2021-2032)
- 10.2.1 China Pet Gut Microbiome Testing Revenue by Type (2021-2026)
- 10.2.2 China Pet Gut Microbiome Testing Revenue by Type (2027-2032)
- 10.3 China Pet Gut Microbiome Testing Revenue Share by Type (2021-2032)
- 10.4 China Pet Gut Microbiome Testing Revenue by Application (2021-2032)
- 10.4.1 China Pet Gut Microbiome Testing Revenue by Application (2021-2026)
- 10.4.2 China Pet Gut Microbiome Testing Revenue by Application (2027-2032)
- 10.5 China Pet Gut Microbiome Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Pet Gut Microbiome Testing Revenue (2021-2032)
- 11.2 Asia Pet Gut Microbiome Testing Revenue by Type (2021-2032)
- 11.2.1 Asia Pet Gut Microbiome Testing Revenue by Type (2021-2026)
- 11.2.2 Asia Pet Gut Microbiome Testing Revenue by Type (2027-2032)
- 11.3 Asia Pet Gut Microbiome Testing Revenue Share by Type (2021-2032)
- 11.4 Asia Pet Gut Microbiome Testing Revenue by Application (2021-2032)
- 11.4.1 Asia Pet Gut Microbiome Testing Revenue by Application (2021-2026)
- 11.4.2 Asia Pet Gut Microbiome Testing Revenue by Application (2027-2032)
- 11.5 Asia Pet Gut Microbiome Testing Revenue Share by Application (2021-2032)
- 11.6 Asia Pet Gut Microbiome Testing Revenue by Country
- 11.6.1 Asia Pet Gut Microbiome Testing Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Pet Gut Microbiome Testing Revenue by Country (2021-2026)
- 11.6.3 Asia Pet Gut Microbiome Testing Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Pet Gut Microbiome Testing Revenue (2021-2032)
- 12.2 SAMEA Pet Gut Microbiome Testing Revenue by Type (2021-2032)
- 12.2.1 SAMEA Pet Gut Microbiome Testing Revenue by Type (2021-2026)
- 12.2.2 SAMEA Pet Gut Microbiome Testing Revenue by Type (2027-2032)
- 12.3 SAMEA Pet Gut Microbiome Testing Revenue Share by Type (2021-2032)
- 12.4 SAMEA Pet Gut Microbiome Testing Revenue by Application (2021-2032)
- 12.4.1 SAMEA Pet Gut Microbiome Testing Revenue by Application (2021-2026)
- 12.4.2 SAMEA Pet Gut Microbiome Testing Revenue by Application (2027-2032)
- 12.5 SAMEA Pet Gut Microbiome Testing Revenue Share by Application (2021-2032)
- 12.6 SAMEA Pet Gut Microbiome Testing Revenue by Country
- 12.6.1 SAMEA Pet Gut Microbiome Testing Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Pet Gut Microbiome Testing Revenue by Country (2021-2026)
- 12.6.3 SAMEA Pet Gut Microbiome Testing Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst